NCSM
NCS Multistage Holdings, Inc.41.02
-2.21-5.11%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
104.23MP/E (TTM)
9.00Basic EPS (TTM)
4.56Dividend Yield
0%Recent Filings
8-K
Q3 revenues rise 6% on acquisition
NCS Multistage Holdings reported Q3 2025 revenues of $46.5 million, up 6% year-over-year, fueled by the late-July acquisition of ResMetrics, which boosted U.S. services by $4.7 million including $2 million from the new unit. Net income dipped to $3.8 million from $4.1 million, yet Adjusted EBITDA held steady at $7.0 million amid Canadian rig slowdowns. Integration with tracer diagnostics advances swiftly. Canada's activity wanes.
10-Q
Q2 FY2025 results
NCS Multistage Holdings swung to profitability in Q2 FY2025 ended June 30, 2025, with revenues climbing 22.8% y/y to $36.5M on surging product sales up 46.0% y/y to $27.8M, fueled by fracturing systems in Canada and the U.S. despite softer rig counts; services dipped 18.7% y/y to $8.7M amid project timing. Gross margin held at 33.7%, down from 38.1% y/y, while operating loss narrowed to $2.0M from $4.2M y/y, thanks to lower SG&A. Diluted EPS of $0.34 reconciles to net income of $0.9M over 2.734M shares. Cash stayed flat at $25.4M, with operating cash flow of $1.9M for H1 (derived) and $7.7M in finance leases; ABL availability hit $17.2M. On July 31, 2025, NCS closed the $5.9M cash acquisition of ResMetrics for tracer diagnostics expansion, assuming debt with up to $1.3M earn-out tied to 2025 tariffs. Patent disputes in Canada linger as a key risk.
8-K
Q2 revenue up 23%; ResMetrics acquired
NCS Multistage Holdings reported Q2 2025 revenues of $36.5 million, up 23% year-over-year, with net income of $0.9 million boosted by a $1.4 million deferred tax allowance release in Canada, and Adjusted EBITDA rising to $2.2 million. The company acquired ResMetrics for $5.9 million cash plus up to $1.3 million earn-out, enhancing its tracer diagnostics with a business posting over $10 million trailing revenue and 30% EBITDA margins. This bolsters NCS's offerings amid softening U.S. rig counts and OPEC+ supply risks. Acquisition integrates seamlessly.
8-K
Annual meeting results approved
NCS Multistage Holdings held its 2025 Annual Meeting on May 21, electing Robert Nipper and Ryan Hummer as Class II directors with strong support—over 88% for each—despite some withheld votes. Stockholders ratified Grant Thornton as auditors nearly unanimously and approved executive compensation and the amended 2017 Equity Incentive Plan by wide margins, with 87.5% turnout. Directors serve until 2028. Governance stays steady.
10-Q
Q1 FY2025 results
NCS Multistage Holdings kicked off 2025 with solid momentum, posting $50.0M in revenues for Q1 ended March 31—a 14.0% y/y jump from $43.9M, fueled by 19.1% growth in Canada to $37.7M while U.S. dipped 6.4% to $9.4M amid project delays. Gross margin expanded to 42.3% from 38.7%, lifting operating income 71.5% y/y to $4.3M and diluted EPS to $1.51 from $0.82, reconciled against 2,686K shares with no anti-dilution flags. Services surged 23.5% y/y to $14.9M, outpacing products at 10.4% to $35.1M, thanks to Middle East tracer diagnostics and North Sea fracturing gigs. Cash dipped to $23.0M with $1.6M operating outflow, yet $26.8M ABL availability cushions the $7.6M finance lease debt. Patent spats in Canada linger as a wildcard.
IPO
Employees
Sector
Industry
ACDC
ProFrac Holding Corp.
3.89-0.27
BKR
Baker Hughes Company
45.02-1.87
FET
Forum Energy Technologies, Inc.
32.83-1.65
HAL
Halliburton Company
27.19-1.22
KLXE
KLX Energy Services Holdings, I
1.64-0.11
NGS
Natural Gas Services Group, Inc
32.48-0.86
NINE
Nine Energy Service, Inc.
0.32-0.01
NOV
NOV Inc.
15.32-0.92
OIS
Oil States International, Inc.
6.78-0.24
WFRD
Weatherford International plc
76.23-2.76